Stockreport

Ventyx Biosciences: Why Caution Should Remain [Seeking Alpha]

Ventyx Biosciences, Inc.  (VTYX) 
PDF VTYX's VTX3232 lowered hsCRP and IL-6, suggesting cardiometabolic benefits, but trial design and biomarker specificity raise concerns about translatability. A short c [Read more]